# Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Olmesartan Medoxomil Tablets Under Fed Conditions

> **NCT03319706** · PHASE1 · COMPLETED · sponsor: **Torrent Pharmaceuticals Limited** · enrollment: 34 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** Torrent's Olmesartan Medoxomil Tablets 40 mg
- **DRUG:** Daiichi Sankyo Inc's Benicar Tablets 40 mg

## Key facts

- **NCT ID:** NCT03319706
- **Lead sponsor:** Torrent Pharmaceuticals Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2017-10-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03319706

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03319706, "Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Olmesartan Medoxomil Tablets Under Fed Conditions". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03319706. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*